ARYx Therapeutics
closedPharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
Launch date
Employees
Market cap
€216k
Enterprise valuation
€216k (Public information from Sep 2024)
Share price
$0.0005 ARYX
Fremont California (HQ)
Authorizing premium user...